Schwabe Pharma Italia
Schwabe Pharma Italia Srl is the Verona-based Italian subsidiary of Germany's Dr. Willmar Schwabe Group, marketing 40+ branded phytopharmaceuticals, medical devices, supplements, cosmetics, and homeopathic products through Italian pharmacies and herbalist shops. It serves consumers and healthcare professionals via proprietary standardized plant extracts (EPs, WS series) and a dedicated medical-rep field force.
- Company typePrivate
- Founded2019
- HeadquartersBolzano Novarese, Italy
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
What Schwabe Pharma Italia does
Schwabe Pharma Italia Srl is the Italian subsidiary of the German Dr. Willmar Schwabe Group, a phytopharmaceutical conglomerate founded in 1866 that describes itself as a world leader in herbal medicines (Farmaco Vegetale). Headquartered in Verona, Italy, the company markets a portfolio of 40+ branded products across nine therapeutic areas: respiratory (Kaloba line based on Pelargonium sidoides EPs 7630), immunological, central nervous system (Vitango, Dormiplant, Nervaxon), gastrointestinal (Gaspan for IBS, Pegaso line), dermatological, women's wellness, emotional (Bach Flowers), general health, and oligoelements. The product mix spans regulated herbal medicinal products, MDR-certified medical devices, food supplements, cosmetics, and homeopathic remedies.
The company's underlying technology rests on proprietary standardized plant extracts — notably the EPs (e.g., EPs 7630) and WS (e.g., WS 1375, WS 1340, WS 1520, WS 1014, WS 5570, WS 1473) series — developed and manufactured within the Schwabe Group under a fully vertically integrated supply chain spanning plant cultivation, extraction, and finished pharmaceutical production. Three new AIFA herbal medicine dossiers are pending, and KalobaTUSS received EU MDR 2017/745 certification in March 2024.
The business model is hybrid B2B/B2C: a field sales force of medical scientific representatives (Informatori Medico-Scientifico) details doctors, while zone-based agents (Agenti) call on pharmacists; downstream, products reach consumers through Italian pharmacies (farmacie) and herbalist shops (erboristerie), supplemented by a toll-free consumer service, a professional Area Riservata portal, and an active trade-show presence (e.g., Cosmofarma). The Italian entity was substantially built through the 2019 acquisition of Pegaso S.r.l. (~60 employees, 60+ SKUs, ~€7M 2018 revenue) and the 2017 acquisition of Loacker Remedia. The company is privately held, with no public revenue disclosure.
Schwabe Pharma Italia firmographics
Firmographics- Name
- Schwabe Pharma Italia
- Legal name
- Schwabe Pharma Italia Srl
- Website
- https://schwabe.it
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Schwabe Pharma Italia Srl is the Verona-based Italian subsidiary of Germany's Dr. Willmar Schwabe Group, marketing 40+ branded phytopharmaceuticals, medical devices, supplements, cosmetics, and homeopathic products through Italian pharmacies and herbalist shops. It serves consumers and healthcare professionals via proprietary standardized plant extracts (EPs, WS series) and a dedicated medical-rep field force.
- Ownership category
- akta.pro rank
Schwabe Pharma Italia industry classification
Industry- Product category
- Phytopharmaceuticals (Herbal Medicines)
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Herbal & Botanical Supplements (CRADAGAD)
- akta.pro secondary industries
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD), Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Healthy Aging & Cognitive Support Supplements (CRADAGAM)
Keywords
Where Schwabe Pharma Italia is headquartered
LocationHeadquarters
- HQ city
- Bolzano Novarese
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Schwabe Pharma Italia business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Phytopharmaceutical Products (Farmaci Vegetali): Prescription and OTC herbal medicines including Kaloba (respiratory), Dormiplant (sleep), Gaspan (gastrointestinal), Vitango (stress), Prostaplant (prostate), Nervaxon (nervous system). Products regulated as medicines with proven efficacy and safety.
- Medical Devices: Class IIa medical devices including KalobaTUSS (cough syrup), KalobaNASO (nasal spray), KalobaGOLA (throat). Products certified under new EU MDR regulation 2017/745.
- Food Supplements (Integratori Alimentari): Dietary supplements including Pegaso line products, AxiCromo, AxiFerro, AxiMagnesio, Oligolito trace elements, FITODrena draining products, and various other nutraceuticals.
- Homeopathic Products: Homeopathic products including Halicar, Dr. Schussler Salts, Homeokind line. Part of the DHU (Deutsche Homoeopathie-Union) portfolio under Schwabe Group.
- Cosmetics: Dermatological products including Halimed cream, Arnica-Salbe, Arnimed gel, Calendumed, and Zanzaker mosquito repellent line.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Schwabe Pharma Italia product offering
Product offeringCore offering
Schwabe Pharma Italia manufactures and distributes a broad portfolio of phytopharmaceutical (herbal) medicines, dietary supplements, medical devices, cosmetics, and homeopathic products in Italy. The portfolio spans respiratory (Kaloba line), gastrointestinal (Gaspan, Pegaso line), central nervous system (Dormiplant, Vitango, Nervaxon), immunological, dermatological, women's health, emotional wellbeing (Bach flowers), and general health/oligoelement segments. The company leverages proprietary standardized plant extracts (EPs and WS series) developed by its German parent and sells through pharmacies and herbalists with field sales support to healthcare professionals.
Product overview
Schwabe Pharma Italia is the Italian subsidiary of the German Schwabe Group, a world leader in herbal medicines (Farmaci Vegetali). The company offers a comprehensive portfolio of natural health products combining Nature and Science, organized across 9 health areas: Respiratory System (featuring Kaloba® line with Pelargonium sidoides EPs® 7630), Immunological Area (Pegaso® IMMUNO, PegaD3®, Nutrivital®), Central Nervous System (Vitango® with Rhodiola rosea WS® 1375, Dormiplant® with Valeriana officinalis, PegaStress®, Nervaxon®), Gastrointestinal Area (Gaspan® with peppermint and caraway oils, Linea Pegaso®, EnziTime®, Zeopan®), Dermatological Area (Halimed®, Halicar®, Arnica-Salbe, Arnimed®, Calendumed®, Zanzaker® line), Women's Wellness (Candinorm® line, Estronorm® line, FreeCist®, Lactogal® Plus, Progenorm®), Emotional Area (Rescue®, Fiori di Bach® Originali), General Health (AxiCromo®, AxiFerro®, AxiMagnesio®, Ferrotone®, FITODrena® line, Homeokind®, Prostaplant®, RegoBasic®, Sali Dr. Schüssler®, TG1 occhi™), and Oligoelements (Oligolito® series with 12 different formulations). The portfolio includes Herbal Medicinal Products, dietary supplements, medical devices, cosmetics, and homeopathic products. The company also offers proprietary plant extracts (EPs® and WS® branded) as key active ingredients. Schwabe maintains complete control of the production chain from seed to finished pharmaceutical product.
Differentiator
Problem solved
Functional benefit
Brands
- Pegaso: Product line specializing in intestinal wellness and dietary supplements, originally an independent Italian company acquired by the Schwabe Group in 2019.
- Mama Natura
- Kaloba
- Gaspan
- Vitango
- Dormiplant
- Halicar
- Homeokind
- Sali Dr. Schüssler
Products and services
- Kaloba® Herbal medicinal product based on Pelargonium sidoides EPs 7630 extract for the treatment of common cold and acute bronchitis, sold through Italian pharmacies.
- KalobaTUSS® sciroppo MDR-certified medical device syrup for dry and productive cough.
- KalobaNASO® spray Nasal spray medical device for respiratory support.
- KalobaGOLA® Medical device product for throat relief.
- Gaspan® Herbal medicinal product combining Mentha piperita WS 1340 and Carum carvi WS 1520 oils in a gastro-protected formulation for irritable bowel syndrome and functional gastrointestinal disorders.
- Vitango® Herbal medicinal product based on Rhodiola rosea WS 1375 extract for stress, fatigue, and central nervous system support.
- Dormiplant® Herbal medicinal product based on Valeriana officinalis WS 1014 and Melissa officinalis WS 1303 for sleep disorders and insomnia.
- Nervaxon® Herbal medicinal product for central nervous system support including nerve health.
- Prostaplant® Herbal medicinal product based on Serenoa repens WS 1473 (saw palmetto) extract for prostate health and benign prostatic hyperplasia support.
- Pegaso® IMMUNO Dietary supplement for immunological support, part of the Pegaso nutraceutical line.
- PegaD3® Vitamin D3 dietary supplement.
- Nutrivital® Nutritional supplement supporting immunological health.
- PegaStress® Dietary supplement formulated for stress management.
- Linea Pegaso® Comprehensive line of intestinal wellness products including supplements and medical devices for digestive health.
- EnziTime® Digestive enzyme supplement to support gastrointestinal function.
- Zeopan® Dietary supplement supporting gastrointestinal health.
- Halimed® crema Topical cream medical device for dermatological conditions.
- Halicar® Homeopathic product for dermatological use.
- Arnica-Salbe Arnica-based topical ointment for bruises and muscle soreness.
- Arnimed® gel Schwabe Arnica-based topical gel.
- Calendumed® Schwabe Calendula-based medical device for skin care and minor wound healing.
- Linea Zanzaker® Product line of repellents and care products for protection against mosquito and tick bites.
- Linea Candinorm® Women's wellness product line addressing candida and intimate hygiene.
- Linea Estronorm® Women's wellness product line addressing menopause symptoms.
- FreeCist® Dietary supplement for urinary tract support.
- Lactogal® Plus Probiotic dietary supplement.
- Progenorm® Dietary supplement supporting women's reproductive health and pregnancy.
- AxiCromo® Chromium dietary supplement for general health.
- AxiFerro® Iron dietary supplement.
- AxiMagnesio® Magnesium dietary supplement offering eight of the most bioavailable magnesium sources.
- Ferrotone® Iron dietary supplement for general health.
- Linea FITODrena® Product line of herbal drainage supplements targeting liver, kidneys, and lymphatic drainage.
- Homeokind® Homeopathic product line for pediatric use.
- RegoBasic® Dietary supplement for pH regulation and metabolic acidosis.
- Sali Dr. Schüssler® Schüssler Salts homeopathic products.
- TG1 occhi™ MIRTIdrop Eye drops medical device.
- Oligolito® DIA Series and Oligoelement Line Oligotherapy product line covering trace element supplementation across multiple diatheses and metabolic functions.
- Rescue® Bach flower remedy for emotional balance in crisis situations.
- Fiori di Bach® Originali Original Bach flower remedies for emotional wellbeing.
Quantifiable outcome
- Gaspan combination of peppermint and caraway oil more effective than single extracts for IBS symptoms
- +1 more outcomes
Companies that use Schwabe Pharma Italia
Customer profileNamed customers3 records
Segments9 records
Ideal customer profiles3 records
Schwabe Pharma Italia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Schwabe Pharma Italia partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Pegaso s.r.l.coreSchwabe Group acquired Pegaso, an Italian nutraceutical company specializing in development, marketing and distribution of high-quality food supplements. Pegaso had 60 employees and 60+ products. Acquisition expanded Schwabe's presence with medical class and broadened product range available to pharmacists. Pegaso had strong reputation for quality and innovation appreciated by doctors. Integration into Schwabe Pharma Italia organization enables wider territorial distribution.
- Loacker RemediacoreAcquisition of Loacker Remedia finalized in 2017, expanding Schwabe Group's natural health product portfolio in Italy.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Schwabe Pharma Italia competitors and assessment
Company assessmentDirect peers
- Aboca: Italian herbal medicines/nutraceutical manufacturer with full seed-to-product vertical integration, broad pharmacy distribution, and similar phytopharmaceutical+medical-device+supplement mix - the most direct competitor in Italy.
- ESI S.r.l. (Rottapharm group): Italian nutraceuticals/herbal supplements company with pharmacy-channel distribution and overlapping product categories (respiratory, sleep, GI, women's wellness) directly competing with Schwabe Italia.
- Specchiasol: Italian producer of herbal medicines, homeopathics, and dietary supplements sold primarily through pharmacies - comparable in portfolio breadth and Italian distribution model.
- Zuccari: Italian natural supplement brand with strong pharmacy presence and categories spanning digestion, weight, joint, and beauty - a like-for-like Italian OTC supplements peer.
- Natural Bradel: Italian herbal/nutraceutical manufacturer distributing through pharmacies and herbalists with comparable line extensions across supplements, syrups, and phytotherapy products.
- Boiron: World-leading homeopathic and herbal medicinal product company; in Italy directly competes with Schwabe Italia's homeopathic portfolio (DHU/Schüssler/Arnica) through pharmacy retail.
- Named Sport / Named Healthcare: Italian nutraceutical and sports nutrition company selling via pharmacy and parapharmacy, competing for the same counter space across herbal and dietary supplement categories.
Broad incumbents
- Weleda: Swiss-German natural cosmetics and anthroposophic medicines company with Italian presence, overlapping in plant-derived dermocosmetics (Halimed/Calendumed) and select herbal medicines.
- Dr. Willmar Schwabe GmbH & Co. KG (parent): The German parent group operating in 60+ countries - directly comparable business model (phytopharmaceutical manufacturing, proprietary WS/EPs extracts) but with global scale rather than Italian focus.
- Laboratoires Pierre Fabre: European dermo-pharmaceutical and herbal medicine group active in Italy, partially overlapping in plant-based medical devices and OTC consumer health (respiratory, dermatology).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Schwabe Pharma Italia social profiles
Digital presenceSchwabe Pharma Italia compliance and trust
Trust signalCompliance3 records
Schwabe Pharma Italia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Schwabe Pharma Italia leadership team
Management profileNumber of profiles
Profiles1 record
Schwabe Pharma Italia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Schwabe Pharma Italia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Schwabe Pharma Italia
What does Schwabe Pharma Italia do?
Schwabe Pharma Italia manufactures and distributes a broad portfolio of phytopharmaceutical (herbal) medicines, dietary supplements, medical devices, cosmetics, and homeopathic products in Italy. The portfolio spans respiratory (Kaloba line), gastrointestinal (Gaspan, Pegaso line), central nervous system (Dormiplant, Vitango, Nervaxon), immunological, dermatological, women's health, emotional wellbeing (Bach flowers), and general health/oligoelement segments. The company leverages proprietary standardized plant extracts (EPs and WS series) developed by its German parent and sells through pharmacies and herbalists with field sales support to healthcare professionals.
Is Schwabe Pharma Italia a public or private company?
Schwabe Pharma Italia is a private company. It is classified as corporate owned and is currently operating.
When was Schwabe Pharma Italia founded?
Schwabe Pharma Italia was founded in 2019. It employs 101 to 250 people.
Where is Schwabe Pharma Italia based?
Schwabe Pharma Italia is headquartered in Bolzano Novarese, Italy, in the Europe region.
How does Schwabe Pharma Italia make money?
Five revenue lines are on record. Phytopharmaceutical Products (Farmaci Vegetali) is the primary driver. The others are medical Devices, food Supplements (Integratori Alimentari), homeopathic Products and cosmetics.
Who are Schwabe Pharma Italia's main competitors?
Direct peers on record are Aboca, ESI S.r.l. (Rottapharm group), Specchiasol, Zuccari, Natural Bradel, Boiron and Named Sport / Named Healthcare. Broad incumbents are Weleda, Dr. Willmar Schwabe GmbH & Co. KG (parent) and Laboratoires Pierre Fabre.
Does Schwabe Pharma Italia have an API?
No public API is recorded for Schwabe Pharma Italia.
What industry is Schwabe Pharma Italia in?
Schwabe Pharma Italia's product category is Phytopharmaceuticals (Herbal Medicines). Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts). Its NAICS code is 325411 and its SIC code is 2833.